Jefferies Reiterates Buy on Tenet Healthcare, Maintains $95 Price Target
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Brian Tanquilut has reiterated a Buy rating on Tenet Healthcare (NYSE:THC) and maintained a $95 price target.
June 14, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Brian Tanquilut reiterated a Buy rating on Tenet Healthcare (NYSE:THC) and maintained a $95 price target.
The Buy rating and maintained $95 price target by Jefferies analyst Brian Tanquilut indicates a positive outlook for Tenet Healthcare's stock in the short term. This news is highly relevant and important for investors in Tenet Healthcare, as it reflects the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100